stroke an overview n.
Skip this Video
Loading SlideShow in 5 Seconds..
Stroke: An Overview PowerPoint Presentation
Download Presentation
Stroke: An Overview

Loading in 2 Seconds...

play fullscreen
1 / 45

Stroke: An Overview - PowerPoint PPT Presentation

Download Presentation
Stroke: An Overview
An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Stroke: An Overview 台北榮民總醫院 神經醫學中心 神經血管科 許立奇 醫師

  2. What Is Stroke ? A stroke occurs when blood flow to the brain is interrupted by a blocked or burst blood vessel.

  3. Definition of Stroke • Stroke (Cerebrovascular accident, CVA): rapidly developing clinical signs of focal or global disturbance of cerebral function, with symptoms lasting 24 hours or longer, or leading to death, with no apparent cause other than a vascular origin WHO, 1976 • Stroke definition by time course: • Transient ischemia attack (TIA): ischemic events < 24 hours without apparent permanent neurological deficits • Stoke in evolution: progressive neurological deficits over time suggesting a widening of the area of ischemia • Completed stroke: ischemic event with persisted deficit

  4. Two Major Types of Stroke

  5. Stroke Subtypes Ischemic Stroke (83%) Hemorrhagic Stroke (17%) Atherothrombotic Cerebrovascular Disease (20%) Intracerebral Hemorrhage(59%) Cryptogenic and Other KnownCause (30%) Subarachnoid Hemorrhage (41%) Embolism (20%) Lacunar (25%) Small vessel disease Albers GW, et al. Chest. 1998;114:683S-698S. Rosamond WD, et al. Stroke. 1999;30:736-743.

  6. Epidemiology ( I ): Global Burden • 15 million nonfatal stroke each year in the world • Second leading cause of death: 5 million each year • Major cause of permanent disability: another 5 million each year • Risk of stroke: age- and sex-dependent • Incidence: varies with geography • 388/100,000 in Russia, 247/100,000 in China to 61/100,000 in Fruili, Italy

  7. Epidemiology ( II ): Taiwan • Thesecondleading cause of death • Incidence: average annual incidence of first-ever stroke in Taiwan aged 36 years old or over is 300/100,000 (CI: 71%, ICH: 22%, SAH: 1%,others: 6%) • Prevalence: 1,642/100,000 (>36 years old)

  8. Pathophysiology of Ischemic Brain Injury • Brain: • 2% of human body’s mass • 20% of cardiac output • Inadequate perfusion: tissue death and functional deficit • Ischemic brain injury: • A series of interlocking thresholds – the “ ischemic thresholds ” • Decrement in regional CBF  key pathologic events

  9. Effects of Reduced CBF Infarction Penumbra Ischemia 50 – 55 25 20 15 8 Edema Loss of Na/K+ electrical pump ↑lactate activity failure; ↓ ATP Normal ml/100g/min Cell Death

  10. Pathophysiology of Ischemic Brain Injury Topography of focal ischemia • Flow gradient: heterogeneous regional CBF reduction after focal ischemia • Densely ischemia region surrounded by areas of less severe CBF reduction • Ischemic penumbra: an area of reduced perfusion sufficient to cause potentially reversible clinical deficits but insufficient to cause disrupted ionic homeostasis

  11. Pathogenesis of Ischaemic Stroke Penumbra Infarction

  12. Ischemic Penumbra: Current Concept

  13. Risk Factors • Importance: • Identifying those at greatest risk for stroke • Providing targets for preventative therapies • Types: • Modifiable • Non-modifiable

  14. Stroke: Non-modifiable Risk factors • Age • Sex • Ethnicity • Prior stroke • Heredity

  15. Hypertension Diabetes Dyslipidemia Atrial fibrillation Other cardiac conditions Cigarette smoke Asymptomatic carotid stenosis Sickle cell disease Postmenopausal hormone therapy Diet and nutrition Physical Inactivity Obesity and body fat distribution Stroke: Well-Documented and Modifiable Risk Factors

  16. Modifiable Risk Factors: Others

  17. Classification of Ischemic Stroke • By vascular territory • Ant. Circulation: carotid arteries • Post. Circulation: VB system • By stroke etiology

  18. Blood Supply to the Brain:Anterior Circulation • Int. Carotid A. • arises from common carotid a. • Branches: anterior cerebral, anterior communicating, middle cerebral, posterior communicating

  19. Blood Supply to the Brain:Anterior Circulation

  20. Blood Supply to the Brain:Posterior Circulation

  21. Brain Structures and Functions

  22. What Is the Cause of Ischemic Stroke? • Atherothrombosis • Embolus: • Material: Red (fibrin rich) or White (platelet rich) • Source: Cardiac? Aortic? Carotid Artery? • Small artery disease • Hypoperfusion:Hemodynamic • Others:arterial dissection, arteritis, etc.

  23. Ischemic Stroke: Atherothrombosis • Thrombotic • Acute occluding clot • Superimposed on chronic narrowing

  24. Ischemic Stroke: Cerebral Embolism • Embolic • Intravascular material, most often a clot, separates proximally • Flows through arterial system until it occludes distally • Atrial fibrillation

  25. Lacunar Syndromes

  26. Ischemic Stroke Subtypes: Data from Taiwan Stroke Registry (2010)

  27. Stroke Warning Signs • Sudden weakness or numbness of the face, arm or leg, especially on one side of the body • Sudden confusion, trouble speaking or understanding • Sudden trouble seeing in one or both eyes • Sudden trouble walking, dizziness/vertigo, loss of balance or coordination • Sudden, severe headaches with no known cause (for hemorrhagic stroke)

  28. Carotid territory Amaurosis fugax Dysphasia Hemiparesis Hemi-sensory loss Vertebrobasilar Hemianopia Quadraparesis Cranial N dysfunction Cerebellar syndrome Crossed deficit Loss of consciousness Localization

  29. Laboratory Examinations • Hb, Hcr, thromb, leuc • glu, CRP, SR, CK, CK-MB, creat • APTT, TT-SPA/INR • Electrolytes, osmolarity • Urine analysis • CSF (if needed for differential diagnosis and only after CT scan, if available) • Others, e.g., coagulation survey, homocysteine for young stroke, rheumotology/immunology screening • Cardiac evaluation: ECG, echocardiography

  30. Intracranial atherosclerosis Penetrating artery disease Flow-reducing carotid stenosis Carotid plaque with arteriogenic emboli Atrial fibrillation Aortic arch plaque Valve disease Cardiogenic emboli Left ventricular thrombi Evaluation of the Vascular System Reprinted with permission from Albers GW, et al. Chest. 2001;119:300S-320S.

  31. Stroke Diagnostic Tests • Brain imaging: CT, MR • Cardiac Imaging: TTE, TEE, heart monitoring • Lipid, coagulation testing • Vascular Imaging: Noninvasive • MR angiography (MRA) Intracranial, extracranial • CT angiography (CTA) Intracranial, extracranial • Ultrasound: Carotid, TCD Invasive • Conventional cerebral angiography Image courtesy of Regional Neurosciences Unit, Newcastle General Hospital, Newcastle, UK.

  32. Diagnosis: CT Scan • Distinguishes reliably between haemorrhagic and ischemic stroke • Detects signs of ischemia as early as 2 h after stroke onset • Identifies haemorrhage immediately • Detects acute SAH in 95% of cases • Helps to identify other neurological diseases (e.g. neoplasms)

  33. CT: Cerebral infarction Brain swelling Focal cortical effacement Ventricular compression

  34. Multimodal CT Imaging CT PCT CTA Vessel Status Tissue Status Perfusion Status CT, computed tomography; PCT, positron computed tomography; CTA, computed tomography angiography. Images courtesy of UCLA Stroke Center.

  35. Differential Diagnosis of Stroke • Ischemic stroke Hemorrhage stroke • Craniocerebral / cervical trauma • Meningitis/encephalitis • Intracranial mass • Tumor • Subdural hematoma • Seizure with persistent neurological signs • Migraine with persistent neurological signs • Metabolic • Hyperglycemia (nonketotic hyperosmolar coma) • Hypoglycemia • Post-cardiac arrest ischemia • Drug/narcotic overdose

  36. Diagnosis: MRI (DWI and PWI) Acute Ischemic Stroke • Diffusion-weighted imaging (DWI) : • Detects areas of restricted diffusion of water • Bright-up in acute ischemic stroke • Differentiation between new and old lesions • Perfusion-weighted imaging (PWI): • Detects abnormal tissue perfusion • Diffusion-perfusion mismatch: • Area of penumbra? • Target of thrombolysis

  37. Multimodal MRI Imaging DWI PWI MRA Vessel Status Perfusion Status Tissue Status DWI, diffusion-weighted imaging; PWI, perfusion-weighted imaging; MRA, magnetic resonance angiography. Images courtesy of UCLA Stroke Center.

  38. Diagnosis: Vascular Imaging Carotid Ultrasound Cerebral Angiography

  39. Management of Cerebrovascular Disease: Current Strategies • Treatment of risk factors in large populations • Treatment of highest risk persons • Management of acute stroke • Prevention and treatment of medical and neurological complications • Rehabilitation • Prevention of recurrent stroke

  40. Strategies for Preventing Stroke and Reducing Stroke Disability stroke mortality blood pressure glucose smoking lipids mass popl. strategy acute treatment recurrent stroke First stroke Secondary prevention high risk strategy Rehabilitation hypertension TIA Atrial fibrillation other vascular disease Stroke related disability

  41. Stroke Therapy: Overview • Risk Factors: • Lifestyle modification • Risk factor management • Acute stroke therapy • Prevention of stroke: • Primary prevention • Secondary prevention

  42. Management of Risk Factors • Non-pharmacological intervention: • Life style modification: cessation of smoking, drinking • Exercise, weight reduction • Pharmacological intervention: • DM, HTN, hyperlipidemia, cardiac diseases,

  43. Management: Improved CBF • Prevention: endarterectomy, stenting • Acute management: thrombolytics – medical and mechanical • Targeting endothelial cell functions (ACEI, calcium blocker, statins, etc.) Brain tissue ischemia Cerebral arterial stenosis/occlusion LAA/CE/SVD/others Decreased CBF Cerebral autoregulation (endothelial function etc)

  44. Antithrombotic Therapies to Prevent Ischemic Stroke • Oral anticoagulants • Antiplatelet agents • Aspirin 50-325 mg/day • Ticlopidine 250 mg twice daily • Clopidogrel 75 mg/day • Aspirin (25 mg) plus extended-release dipyridamole (200 mg) twice a day